ReviewNeurology2013
The coming crisis: obtaining care for the growing burden of neurodegenerative conditions.
Review in Neurology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 93 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Remote Access to Care, Everywhere: Using Telemedicine to Deliver Patient-centered Care to Patients With Parkinson Disease
Impact of Non-traditional Guitar Group Instruction on Functional Movement and Well-being in Parkinson's Disease Patients
Who cites it
93 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Palliative Care Intervention Trials for Adults Living With Progressive Central Nervous System Diseases and Their Caregivers: A Systematic Review.Journal of pain and symptom management · 2022Pooled it
- Integrated multi-cohort transcriptional meta-analysis of neurodegenerative diseases.Acta neuropathologica communications · 2014Pooled it
- Feasibility, Effectiveness, and Acceptability of a Telemedicine Neurological Consultation for Drug-Induced Movement Disorders; A Randomized Pilot Study.Tremor and other hyperkinetic movements (New York, N.Y.) · 2025Trial
- IN-HOME-PDCaregivers: The effects of a combined home visit and peer mentoring intervention for caregivers of homebound individuals with advanced Parkinson's disease.Parkinsonism & related disorders · 2023Trial
- Comparison of Integrated Outpatient Palliative Care With Standard Care in Patients With Parkinson Disease and Related Disorders: A Randomized Clinical Trial.JAMA neurology · 2020Trial
- Trial
- National Randomized Controlled Trial of Virtual House Calls for People with Parkinson's Disease: Interest and Barriers.Telemedicine journal and e-health : the official journal of the American Telemedicine Association · 2016Trial
- Virtual house calls for Parkinson disease (Connect.Parkinson): study protocol for a randomized, controlled trial.Trials · 2014Trial
- Article
- Deciphering the regulatory landscape of enhancer RNAs in health and disease.Signal transduction and targeted therapy · 2026Review
- US Burden of Disorders Affecting the Nervous System: From the Global Burden of Disease 2021 Study.JAMA neurology · 2026Article
- Budget impact analysis of deep brain stimulation devices with different longevity in Parkinson's disease: insights from real-world data.Frontiers in public health · 2026Observational
- The design and development of LRRK2 inhibitors as novel therapeutics for Parkinson's disease.Future medicinal chemistry · 2025Review
- Disparities in glaucoma and macular degeneration healthcare utilization among persons living with dementia in the United States.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2024Article
- Education Research: Observational Study of Educational Debt Among US Medical Graduates Entering Neurology, 2010-2021.Neurology. Education · 2024Article
- Editorial: The (un)desirability of cell death in health and disease: emerging modulators and their mechanisms.Frontiers in cell and developmental biology · 2024Article
- Blood-based biological ageing and red cell distribution width are associated with prevalent Parkinson's disease: findings from a large Italian population cohort.Frontiers in endocrinology · 2024Article
- DOPA decarboxylase is an emerging biomarker for Parkinsonian disorders including preclinical Lewy body disease.Nature aging · 2023Article
- Classification of mild Parkinson's disease: data augmentation of time-series gait data obtained via inertial measurement units.Scientific reports · 2023Article
- Neurological update: the palliative care landscape for atypical parkinsonian syndromes.Journal of neurology · 2023Article
33 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
Authors and funding
4 authors.
Funding
Abstract
As the U.S. population ages, the burden of neurodegenerative disorders, including Alzheimer disease and Parkinson disease, will increase substantially. However, many of these patients and their families currently do not receive neurologic care. For example, a recent study found that over 40% of Medicare beneficiaries with an incident Parkinson disease diagnosis did not receive neurologist care early after diagnosis and those who did not were more likely to fracture a hip, be placed in a nursing home, and die. While geography, age, race, and sex likely contribute to these observed disparities in care and outcomes, a large barrier may be Medicare's reimbursement policies, which value procedures over care. With further reductions in Medicare reimbursement constantly on the horizon, the devaluing of clinical care will likely continue. Rather than guaranteeing access to care, Medicare's reimbursement policies may increasingly be an impediment to care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.